Exor N.V. (EXXRF)
OTC: EXXRF
· Real-Time Price · USD
101.30
0.00 (0.00%)
At close: Jul 01, 2025, 3:33 PM
Exor Income Statement
Financials in EUR. Fiscal
year is
January - December.
Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 38.52B | 41.63B | 44.74B | 44.63B | 44.53B | 43.19B | 41.84B | 39B | 36.16B | 34.89B | 33.62B | 30.93B | 28.25B | 27.52B |
Cost of Revenue | 17.59B | 25.51B | 33.43B | 33.64B | 33.84B | 33.09B | 32.34B | 30.17B | 28B | 26.99B | 25.98B | 23.52B | 21.07B | 21.5B |
Gross Profit | 20.93B | 16.12B | 11.31B | 11B | 10.68B | 10.09B | 9.51B | 8.83B | 8.16B | 7.9B | 7.64B | 7.41B | 7.18B | 6.02B |
Operating Income | 17.78B | 11.53B | 5.29B | 5.08B | 4.88B | 4.5B | 4.11B | 3.71B | 3.32B | 3.23B | 3.15B | 3.24B | 3.33B | 2.16B |
Interest Income | 16M | 847.5M | 1.68B | 2.13B | 2.58B | 2.26B | 1.94B | 2.04B | 2.14B | 2.03B | 1.92B | 1.48B | 1.04B | 708M |
Pretax Income | 18.5B | 13.18B | 7.87B | 7.59B | 7.32B | 6.61B | 5.9B | 5.42B | 4.93B | 4.79B | 4.65B | 4.08B | 3.5B | 1.65B |
Net Income | 16.73B | 10.46B | 4.19B | 3.95B | 3.7B | 3.28B | 2.86B | 2.35B | 1.83B | 1.72B | 1.61B | 514.5M | -584M | -422.5M |
Selling & General & Admin | 1.82B | 2.68B | 3.55B | 3.56B | 3.58B | 3.45B | 3.32B | 3.12B | 2.92B | 2.8B | 2.68B | 2.45B | 2.21B | 2.24B |
Research & Development | 1.33B | 1.9B | 2.47B | 2.36B | 2.24B | 2.17B | 2.09B | 2.14B | 2.19B | 2.13B | 2.08B | 2.53B | 2.99B | 2.98B |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.6B | 4.13B | 5.67B | 5.43B | 5.74B | 5.54B | 5.35B | 5.36B | 5.37B | 5.13B | 4.9B | 4.57B | 4.24B | 4.47B |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.18B | 29.64B | 39.1B | 39.07B | 39.59B | 38.64B | 37.69B | 35.53B | 33.37B | 32.12B | 30.88B | 28.1B | 25.31B | 25.97B |
Income Tax Expense | 512M | 803.5M | 1.09B | 1.13B | 1.16B | 1.11B | 1.06B | 1.24B | 1.42B | 1.36B | 1.3B | 893M | 484M | 329M |
Shares Outstanding (Basic) | 219.35M | 219.35M | 226.14M | 226.16M | 230.15M | 230.15M | 235.33M | 235.33M | 231.85M | 231.85M | 209.34M | 209.34M | 231.36M | 231.36M |
Shares Outstanding (Diluted) | 219.35M | 219.35M | 225.58M | 225.15M | 230.15M | 230.15M | 234.66M | 234.66M | 231.85M | 231.85M | 209.34M | 209.34M | 231.36M | 231.36M |
EPS (Basic) | 76.00 | 47.19 | 18.38 | 17.16 | 15.94 | 14.09 | 12.24 | 10.18 | 8.12 | 7.66 | 7.20 | 2.18 | -2.84 | -2.15 |
EPS (Diluted) | 76.04 | 47.23 | 18.42 | 17.19 | 15.96 | 14.11 | 12.26 | 10.19 | 8.12 | 7.66 | 7.20 | 2.18 | -2.84 | -2.15 |
EBITDA | 18.53B | 12.48B | 6.43B | 6.21B | 5.98B | 5.57B | 5.15B | 4.71B | 4.28B | 4.17B | 4.05B | 4.63B | 5.21B | 4.04B |
EBIT | 17.78B | 11.54B | 5.29B | 5.09B | 4.88B | 4.5B | 4.11B | 3.71B | 3.32B | 3.23B | 3.15B | 3.24B | 3.33B | 2.16B |
Depreciation & Amortization | 749M | 943.5M | 1.14B | 1.12B | 1.1B | 1.07B | 1.04B | 1B | 961M | 932.5M | 904M | 1.39B | 1.88B | 1.88B |